Texas Children's Hospital in Austin performs fetal blood transfusion to save the life of baby exposed to childhood illness.

Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program.

A new study led by scientists at the Perception Dynamics Institute and the University of California San Diego demonstrates ...

Gegen, 35, had been the picture of health. He has no memory of the next 10 days, but he benefited from a new approach to how ...

State auditors flagged mismanagement and political influence in AICS and AKAP, yet the bicameral committee still approved ...

Another driver arrested in one of last week’s RIDE programs was charged with impaired driving at a holiday season spot check ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupix ...

US POINTER, a healthy lifestyle intervention, helped participants improve blood pressure regulation of blood flow to the brain, reduced sleep apnea respiratory events, and increased cognitive ...

The program, included in President Donald Trump’s “Big Beautiful Bill,” offers a generous tax incentive to people who donate to scholarship organizations.

Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...

Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for ...

Trump intends to move marijuana from a Schedule I drug, a category that includes dangerous drugs that have no accepted ...